APO 150 (Nizatidine 150 mg)
Pill imprint APO 150 has been identified as Nizatidine 150 mg.
Nizatidine is used in the treatment of gerd; erosive esophagitis; duodenal ulcer; indigestion; duodenal ulcer prophylaxis (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
- APO 150
- 150 mg
- White & Yellow
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Apotex Corp.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|55045-3748||Dispensing Solutions Inc. (repackager)|
|55887-0153||Diversified Healthcare Services Inc (repackager)|
|23490-6010||Palmetto State Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about nizatidine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.